Virtus ETF Advisers LLC - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 95 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q2 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$320,668
+9.2%
18,461
-11.5%
0.20%
+12.1%
Q2 2023$293,582
+38.5%
20,851
+5.9%
0.17%
+48.7%
Q1 2023$211,929
-26.9%
19,696
+1.8%
0.12%
-22.5%
Q4 2022$289,788
-20.6%
19,345
-31.9%
0.15%
+3.4%
Q3 2022$365,000
+34.7%
28,407
+1.5%
0.15%
+46.0%
Q2 2022$271,000
-9.1%
27,992
-6.8%
0.10%
-24.8%
Q1 2022$298,000
-15.6%
30,0210.0%0.13%0.0%
Q4 2021$353,000
+3.2%
30,021
+0.0%
0.13%
-11.3%
Q3 2021$342,000
-25.0%
30,009
-8.4%
0.15%
-20.2%
Q2 2021$456,000
+60.0%
32,762
+112.5%
0.19%
+56.7%
Q1 2021$285,000
+6.3%
15,414
+1.8%
0.12%
+8.1%
Q4 2020$268,000
+22.4%
15,148
+5.8%
0.11%
-3.5%
Q3 2020$219,000
-47.2%
14,317
-12.0%
0.12%
-41.6%
Q2 2020$415,000
+95.8%
16,274
+38.3%
0.20%
-56.3%
Q1 2019$212,000
-44.2%
11,763
-13.1%
0.45%
+593.8%
Q4 2018$380,00013,5360.06%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q2 2022
NameSharesValueWeighting ↓
Spearhead Capital Advisors, LLC 202,580$2,601,0002.82%
Lion Point Capital, LP 480,000$5,140,0001.13%
HHLR ADVISORS, LTD. 2,920,023$37,493,0000.99%
TANG CAPITAL MANAGEMENT LLC 600,000$7,704,0000.94%
Rubric Capital Management LP 1,446,107$18,568,0000.94%
AlphaCentric Advisors LLC 43,000$552,0000.57%
RICE HALL JAMES & ASSOCIATES, LLC 749,933$9,629,0000.56%
Parkman Healthcare Partners LLC 126,192$1,620,0000.46%
Birchview Capital, LP 30,000$385,0000.27%
Baker Brothers Advisors 2,799,577$35,947,0000.24%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders